Lista de obras -

A polygenic risk score for multiple myeloma risk prediction

artículo científico publicado en 2022

Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective--a report by Polish Myeloma Study Group.

artículo científico publicado en 2014

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium

scientific article published on 20 November 2019

Charakterystyka chorych na przewlekłą białaczkę mielomonocytową na podstawie ogólnopolskiego prospektywnego rejestru MDS/CMML

artículo científico publicado en 2015

Charakterystyka chorych na zespoły mielodysplastyczne na podstawie ogólnopolskiego prospektywnego rejestru MDS

artículo científico publicado en 2015

Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival

scientific article published on 05 November 2020

Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)

scientific article published on 01 May 2018

Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma

artículo científico publicado en 2014

Demographic, Hematologic, and Clinical Features of Myelodysplastic Syndrome Patients: Results from the First Polish Myelodysplastic Syndrome Registry

artículo científico publicado en 2015

Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors

artículo científico publicado en 2020

Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

artículo científico publicado en 2021

Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

article

Genetically determined telomere length and multiple myeloma risk and outcome

artículo científico publicado en 2021

Hiperferrytynemia jest związana z gorszym rokowaniem u chorych na zespoły mielodysplastyczne – dane z pierwszego Polskiego Rejestru MDS PALG

artículo científico publicado en 2015

Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group

artículo científico publicado en 2018

Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.

artículo científico publicado en 2019

Identification of miRSNPs associated with the risk of multiple myeloma.

artículo científico publicado en 2016

Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study

artículo científico publicado en 2020

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia

scientific article published on 12 October 2020

Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study

scientific article published on 23 January 2019

Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.

artículo científico publicado en 2017

Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.

artículo científico publicado en 2017

Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry

artículo científico publicado en 2016

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.

artículo científico publicado en 2016

The role of FDG-PET in Hodgkin lymphoma

artículo científico publicado en 2017

Lista de obras de

A polygenic risk score for multiple myeloma risk prediction

Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective--a report by Polish Myeloma Study Group.

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium

Charakterystyka chorych na przewlekłą białaczkę mielomonocytową na podstawie ogólnopolskiego prospektywnego rejestru MDS/CMML

Charakterystyka chorych na zespoły mielodysplastyczne na podstawie ogólnopolskiego prospektywnego rejestru MDS

Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival

Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)

Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma

Demographic, Hematologic, and Clinical Features of Myelodysplastic Syndrome Patients: Results from the First Polish Myelodysplastic Syndrome Registry

Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors

Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

Genetically determined telomere length and multiple myeloma risk and outcome

Hiperferrytynemia jest związana z gorszym rokowaniem u chorych na zespoły mielodysplastyczne – dane z pierwszego Polskiego Rejestru MDS PALG

Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group

Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.

Identification of miRSNPs associated with the risk of multiple myeloma.

Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia

Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study

Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.

Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.

Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.

The role of FDG-PET in Hodgkin lymphoma